![]() |
12:30-14:00
Lunch Symposium organized by GlaxoSmithKline Biologicals
BECAUSE CERVICAL CANCER PREVENTION MATTERS
Chairs:
Prof. Eduardo Franco, Division of Cancer Epidemiology, McGill University, Montreal, Canada
Dr. Hugues Bogaerts, GlaxoSmithKline Biologicals, Belgium
|
Welcome and introduction |
Prof. Eduardo Franco, Division of Cancer Epidemiology, McGill University, Montreal, QC, Canada |
|
Cervical cancer vaccination: |
Dr. Swee Chong Quek, Department of Gynaecological Oncology, KK Women’s & Children’s Hospital, Singapore |
|
Immunology of HPV infection: Implications for vaccine development |
Prof. Lutz Gissman, German Cancer Research Center, Heidelberg, Germany |
|
Cervical cancer vaccination: |
Prof. Fred Aoki, Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB, Canada |
|
All about preventing more cervical cancers |
Prof. Jack Cuzick, UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London, United Kingdom |
Learning Objectives:
- To increase awareness of cervical cancer and the need for the most extensive prevention possible
- To discuss the development vision of Cervarix and give an update on the latest clinical data from pivotal phase II and III trials
- To discuss the value of vaccination and screening in cervical cancer prevention
- To discuss the population impact that can be expected from primary and secondary prevention of cervical cancer in a real world setting



